XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair value of financial instruments and marketable securities (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities that are required to be measured at fair value on a recurring basis
The following represents the fair value using the hierarchy described above for the Company’s financial assets and liabilities that are required to be measured at fair value on a recurring basis as of March 31, 2017 and December 31, 2016:
 
 
 
March 31, 2017
 
 
Total
 
Quoted prices
in active
markets for
identical assets
(level 1)
 
Significant
other
observable
inputs
(level 2)
 
Significant
unobservable
inputs
(level 3)
Marketable securities
 
$
148,471

 
$

 
$
148,471

 
$

Warrant liability
 
$
1

 
$

 
$

 
$
1

Stock appreciation rights liability
 
$
265

 
$

 
$

 
$
265


 
 
December 31, 2016
 
 
Total
 
Quoted prices
in active
markets for
identical assets
(level 1)
 
Significant
other
observable
inputs
(level 2)
 
Significant
unobservable
inputs
(level 3)
Marketable securities
 
$
173,345

 
$

 
$
173,345

 
$

Warrant Liability
 
$
1

 
$

 
$

 
$
1

Stock appreciation rights liability
 
$
865

 
$

 
$

 
$
865

Summary of marketable securities accounted for as available-for-sale securities
The following is a summary of marketable securities accounted for as available-for-sale securities at March 31, 2017 and December 31, 2016:
 
 
March 31, 2017
 
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
 
 
Gains
 
Losses
 
Commercial paper
 
$
19,162

 
$
35

 
$

 
$
19,197

Corporate debt securities
 
126,134

 
23

 
(84
)
 
126,073

Government obligations
 
3,201

 

 

 
3,201

 
 
$
148,497

 
$
58

 
$
(84
)
 
$
148,471

 
 
 
December 31, 2016
 
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
 
 
Gains
 
Losses
 
Commercial paper
 
$
12,919

 
$
47

 
$

 
$
12,966

Corporate debt securities
 
153,240

 
52

 
(103
)
 
153,189

Government obligations
 
7,188

 
2

 

 
7,190

 
 
$
173,347

 
$
101

 
$
(103
)
 
$
173,345

Schedule of marketable securities on the balance sheet
Marketable securities on the balance sheet at March 31, 2017 and December 31, 2016 mature as follows:
 
 
March 31, 2017
 
 
Less Than
12 Months
 
More Than
12 Months
Commercial paper
 
$
19,197

 
$

Corporate debt securities
 
122,077

 
3,995

Government obligations
 
3,202

 

Total Marketable securities
 
$
144,476

 
$
3,995

 
 
December 31, 2016
 
 
Less Than
12 Months
 
More Than
12 Months
Commercial paper
 
$
12,966

 
$

Corporate debt securities
 
137,196

 
15,993

Government obligations
 
7,190

 

Total Marketable securities
 
$
157,352

 
$
15,993

Summary of changes in the fair value of the Company's Level 3 valuation for warrant liability and SARs liability
The table presented below is a summary of changes in the fair value of the Company’s Level 3 valuations for the warrant liability and SARs liability for the period ended March 31, 2017:
 
 
Level 3 liabilities
 
 
Warrants
 
SARs
Beginning balance as of December 31, 2016
 
$
1

 
$
865

Change in fair value
 

 
464

Payments
 

 
(1,064
)
Ending balance as of March 31, 2017
 
$
1

 
$
265